FI973733L - Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi - Google Patents
Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi Download PDFInfo
- Publication number
- FI973733L FI973733L FI973733A FI973733A FI973733L FI 973733 L FI973733 L FI 973733L FI 973733 A FI973733 A FI 973733A FI 973733 A FI973733 A FI 973733A FI 973733 L FI973733 L FI 973733L
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- pharmaceutical
- pharmaceutical preparation
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (33)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI973733A FI109088B (fi) | 1997-09-19 | 1997-09-19 | Tabletti ja menetelmä sen valmistamiseksi |
| TR2000/00722T TR200000722T2 (tr) | 1997-09-19 | 1998-09-18 | Silikatlı küçük kristalli selüloz içeren farmakolojik ilaç. |
| JP2000512526A JP3589977B2 (ja) | 1997-09-19 | 1998-09-18 | 活性成分としてクロドロン酸塩および賦形剤としてケイ化微晶質セルロースを含む医薬製剤 |
| IL13513098A IL135130A (en) | 1997-09-19 | 1998-09-18 | Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient |
| EA200000317A EA002331B1 (ru) | 1997-09-19 | 1998-09-18 | Фармацевтический препарат, содержащий клодронат в качестве активного ингредиента и агрегат микрокристаллической целлюлозы и диоксида кремния в качестве наполнителя |
| NZ503766A NZ503766A (en) | 1997-09-19 | 1998-09-18 | Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient |
| AU92685/98A AU737738B2 (en) | 1997-09-19 | 1998-09-18 | Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient |
| KR1020007002955A KR20010024184A (ko) | 1997-09-19 | 1998-09-18 | 활성 성분으로 클로드로네이트, 부형제로 실리시파이드미세결정성 셀룰로즈를 함유하는 의약 제제 |
| CZ20000787A CZ298675B6 (cs) | 1997-09-19 | 1998-09-18 | Farmaceutický prostredek obsahující klodronát a mikrokrystalickou celulózu s oxidem kremicitým |
| HK01100766.1A HK1031325B (en) | 1997-09-19 | 1998-09-18 | Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient |
| HU0004383A HU226118B1 (en) | 1997-09-19 | 1998-09-18 | Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient |
| EP98945336A EP1027037B1 (en) | 1997-09-19 | 1998-09-18 | Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient |
| AT98945336T ATE255410T1 (de) | 1997-09-19 | 1998-09-18 | Arzneimittel, das clodronat als wirkstoff und mit siliciumdioxid behandelte mikrokristalline cellulose als füllstoff enthält |
| UA2000042105A UA73078C2 (uk) | 1997-09-19 | 1998-09-18 | Фармацевтичний препарат у вигляді таблеток на основі солі дихлорметилендифосфорної кислоти та силікатованої мікрокристалічної целюлози та спосіб його одержання |
| SK393-2000A SK284088B6 (sk) | 1997-09-19 | 1998-09-18 | Farmaceutický prostriedok obsahujúci klodronát ako aktívne činidlo, spôsob výroby prostriedku a použitie mikrokryštalickej celulózy na jeho výrobu |
| CA002301185A CA2301185C (en) | 1997-09-19 | 1998-09-18 | Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient |
| DE1027037T DE1027037T1 (de) | 1997-09-19 | 1998-09-18 | Arzneimittel, das clodronat als wirkstoff und mit siliciumdioxid behandelte mikrokristalline cellulose als füllsstoff enhält |
| PT98945336T PT1027037E (pt) | 1997-09-19 | 1998-09-18 | Composicao farmaceutica que compreende clodronato como ingredientes activo e celulose microcristalina silicificada como excipiente |
| PL339290A PL191166B1 (pl) | 1997-09-19 | 1998-09-18 | Preparat farmaceutyczny zawierający klodronian, sposób jego wytwarzania i zastosowanie krzemionkowanej celulozy mikrokrystalicznej |
| BR9812480-3A BR9812480A (pt) | 1997-09-19 | 1998-09-18 | "preparação farmacêutica compreendendo clodronato como ingrediente ativo e celulose microcristalina como excipiente, processo de fabricação e uso de celulose microcristalina siliciada na fabricação de dita preparação farmacêutica" |
| CN98809173A CN1124130C (zh) | 1997-09-19 | 1998-09-18 | 含氯甲双磷酸盐活性成分和硅化微晶纤维素赋形剂的药物制剂 |
| IDW20000735A ID24423A (id) | 1997-09-19 | 1998-09-18 | Sediaan farmasi yang terdiri dari klodronat sebagai bahan aktif dan selulosa mikrokristalin tersilisifikasi sebagai eksipien |
| HR20000142A HRP20000142B1 (en) | 1997-09-19 | 1998-09-18 | Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient |
| DE29824938U DE29824938U1 (de) | 1997-09-19 | 1998-09-18 | Pharmazeutische Zubereitung, die Clodronat als Wirkstoff und silifizierte mikrokristalline Cellulose als Exzipienten umfasst |
| DE69820287T DE69820287T2 (de) | 1997-09-19 | 1998-09-18 | Pharmazeutische Zubereitung, die Chlodronat als Wirkstoff und silicifizierte mikrokristalline Cellulose als Exipienten umfasst |
| DK98945336T DK1027037T3 (da) | 1997-09-19 | 1998-09-18 | Farmaceutisk præparat som indeholder clodronat som aktiv ingrediens og forkislet mikrokrystallinsk cellulose som excipiens |
| ES98945336T ES2212341T3 (es) | 1997-09-19 | 1998-09-18 | Preparacion farmaceutica que comprende clodronato como ingrediente activo y celulosa microcristalina modificada con silice como excipiente. |
| EEP200000096A EE04218B1 (et) | 1997-09-19 | 1998-09-18 | Toimeainena klodronaati ja ekstsipiendina ränistatud mikrokristallilist tselluloosi sisaldav farmatseutiline preparaat ning farmatseutilise preparaadi tootmismeetod |
| SI9830599T SI1027037T1 (en) | 1997-09-19 | 1998-09-18 | Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient |
| PCT/FI1998/000735 WO1999015155A1 (en) | 1997-09-19 | 1998-09-18 | Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient |
| IS5404A IS5404A (is) | 1997-09-19 | 2000-03-14 | Lyfjablanda sem inniheldur klódrónat sem virkt innihaldsefni og síliseraðan örkristallaðan sellulósa sem burðarefni |
| NO20001417A NO327728B1 (no) | 1997-09-19 | 2000-03-17 | Farmasoytisk preparat omfattende klodronat som aktiv bestanddel samt silisifiert mikrokrystallinsk cellulose som eksipient |
| BG104265A BG64886B1 (bg) | 1997-09-19 | 2000-03-22 | Фармацевтичен препарат, съдържащ клодронат като активен компонент и силикатизирана микрокристална целулоза като пълнител |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI973733A FI109088B (fi) | 1997-09-19 | 1997-09-19 | Tabletti ja menetelmä sen valmistamiseksi |
| FI973733 | 1997-09-19 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI973733A0 FI973733A0 (fi) | 1997-09-19 |
| FI973733L true FI973733L (fi) | 1999-03-20 |
| FI109088B FI109088B (fi) | 2002-05-31 |
Family
ID=8549561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI973733A FI109088B (fi) | 1997-09-19 | 1997-09-19 | Tabletti ja menetelmä sen valmistamiseksi |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP1027037B1 (fi) |
| JP (1) | JP3589977B2 (fi) |
| KR (1) | KR20010024184A (fi) |
| CN (1) | CN1124130C (fi) |
| AT (1) | ATE255410T1 (fi) |
| AU (1) | AU737738B2 (fi) |
| BG (1) | BG64886B1 (fi) |
| BR (1) | BR9812480A (fi) |
| CA (1) | CA2301185C (fi) |
| CZ (1) | CZ298675B6 (fi) |
| DE (3) | DE29824938U1 (fi) |
| DK (1) | DK1027037T3 (fi) |
| EA (1) | EA002331B1 (fi) |
| EE (1) | EE04218B1 (fi) |
| ES (1) | ES2212341T3 (fi) |
| FI (1) | FI109088B (fi) |
| HR (1) | HRP20000142B1 (fi) |
| HU (1) | HU226118B1 (fi) |
| ID (1) | ID24423A (fi) |
| IL (1) | IL135130A (fi) |
| IS (1) | IS5404A (fi) |
| NO (1) | NO327728B1 (fi) |
| NZ (1) | NZ503766A (fi) |
| PL (1) | PL191166B1 (fi) |
| PT (1) | PT1027037E (fi) |
| SI (1) | SI1027037T1 (fi) |
| SK (1) | SK284088B6 (fi) |
| TR (1) | TR200000722T2 (fi) |
| UA (1) | UA73078C2 (fi) |
| WO (1) | WO1999015155A1 (fi) |
Families Citing this family (86)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395303B1 (en) | 1996-06-10 | 2002-05-28 | Edward Mendell Co., Inc. | Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose |
| SE9901272D0 (sv) * | 1999-04-09 | 1999-04-09 | Astra Ab | New improved formulation |
| SE9903345D0 (sv) | 1999-09-17 | 1999-09-17 | Astra Pharma Prod | Novel process |
| DE10006125C2 (de) * | 2000-02-11 | 2003-08-28 | Kallies Feinchemie Ag | Modifizierte Mikrocellulose |
| US6399101B1 (en) | 2000-03-30 | 2002-06-04 | Mova Pharmaceutical Corp. | Stable thyroid hormone preparations and method of making same |
| HU228400B1 (en) * | 2000-06-20 | 2013-03-28 | Novartis Ag | The use of bisphosphonates for treatment of osteoporosis |
| SI1296689T1 (sl) * | 2000-06-20 | 2006-08-31 | Novartis Ag | Nacin dajanja pacientu bisfosfonatov |
| US6753017B2 (en) | 2001-11-07 | 2004-06-22 | Jrs Pharma Lp | Process for preparing dry extracts |
| EP1509204A4 (en) * | 2001-11-29 | 2005-07-13 | Rettenmaier & Soehne Gmbh & Co | AGGLOMERATED PARTICLES WITH AN ACTIVE SUBSTANCE PREPARED WITH MELTED MICROCRYSTALLINE CELLULOSE |
| GB0209265D0 (en) | 2002-04-23 | 2002-06-05 | Novartis Ag | Organic compounds |
| US20040109889A1 (en) | 2002-12-04 | 2004-06-10 | Bunick Frank J. | Surface treatment composition for soft substrates |
| US7862552B2 (en) | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
| ES2400006T3 (es) * | 2008-04-23 | 2013-04-04 | Farmasierra Manufacturing, S.L. | Formulación farmacéutica mejorada a base de ibuprofeno y codeína |
| US8603527B2 (en) | 2010-10-25 | 2013-12-10 | Signal Pharmaceuticals, Llc | Pharmaceutical formulations of a substituted diaminopurine |
| CN114146079A (zh) * | 2012-02-07 | 2022-03-08 | 比奥根玛公司 | 含有富马酸二甲酯的药物组合物 |
| US9877977B2 (en) | 2012-05-14 | 2018-01-30 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome |
| US10016445B2 (en) | 2012-05-14 | 2018-07-10 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome |
| US10016446B2 (en) | 2012-05-14 | 2018-07-10 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating Paget's disease of bone |
| US10092581B2 (en) | 2014-05-15 | 2018-10-09 | Antecip Bioventures Ii Llc | Osteoclast inhibitors such as zoledronic acid for low back pain treatment |
| US9782421B1 (en) | 2012-05-14 | 2017-10-10 | Antecip Bioventures Ii Llc | Neridronic acid molecular complex for treating complex regional pain syndrome |
| US8802658B2 (en) | 2012-05-14 | 2014-08-12 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating disease |
| US9949993B2 (en) | 2012-05-14 | 2018-04-24 | Antecip Bioventures Ii Llc | Compositions for administration of zoledronic acid or related compounds for treating low back pain |
| US9707247B2 (en) | 2012-05-14 | 2017-07-18 | Antecip Bioventures Ii Llc | Compositions for administration of zoledronic acid or related compounds for treating low back pain |
| US9895383B2 (en) | 2012-05-14 | 2018-02-20 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome |
| US9694023B2 (en) | 2012-05-14 | 2017-07-04 | Antecip Bioventures Ii Llc | Methods for the safe administration of imidazole or imidazolium compounds |
| US10039773B2 (en) | 2012-05-14 | 2018-08-07 | Antecip Bioventures Ii Llc | Neridronic acid for treating arthritis |
| US9861648B2 (en) | 2012-05-14 | 2018-01-09 | Antecip Boiventures Ii Llc | Osteoclast inhibitors for knee conditions |
| US9707245B2 (en) | 2012-05-14 | 2017-07-18 | Antecip Bioventures Ii Llc | Neridronic acid for treating complex regional pain syndrome |
| US10028969B2 (en) | 2012-05-14 | 2018-07-24 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome |
| US9700570B2 (en) | 2014-05-27 | 2017-07-11 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome |
| US9211257B2 (en) | 2012-05-14 | 2015-12-15 | Antecip Bioventures Ii Llc | Osteoclast inhibitors for knee conditions |
| US9999628B2 (en) | 2012-05-14 | 2018-06-19 | Antecip Bioventures Ii Llc | Neridronic acid for treating complex regional pain syndrome |
| US9901589B2 (en) | 2012-05-14 | 2018-02-27 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome |
| US9867839B2 (en) | 2012-05-14 | 2018-01-16 | Antecip Bioventures Ii Llc | Osteoclast inhibitors for joint conditions |
| US9675626B2 (en) | 2012-05-14 | 2017-06-13 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome |
| US9956237B2 (en) | 2012-05-14 | 2018-05-01 | Antecip Bioventures Ii Llc | Osteoclast inhibitors for knee conditions |
| US9956238B2 (en) | 2014-05-15 | 2018-05-01 | Antecip Bioventures Ii Llc | Compositions for administration of zoledronic acid or related compounds for treating low back pain |
| US9867840B2 (en) | 2014-05-27 | 2018-01-16 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome |
| US10111837B2 (en) | 2012-05-14 | 2018-10-30 | Antecip Bioventures Ii Llc | Dosage forms for oral administration of zoledronic acid or related compounds |
| US10463682B2 (en) | 2012-05-14 | 2019-11-05 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating low back pain |
| US10080765B2 (en) | 2012-05-14 | 2018-09-25 | Antecip Bioventures Ii Llc | Neridronic acid for treating complex regional pain syndrome |
| US9943531B2 (en) | 2014-08-08 | 2018-04-17 | Antecip Bioventures Ii Llc | Osteoclast inhibitors such as zoledronic acid for low back pain treatment |
| US10173986B2 (en) | 2012-05-14 | 2019-01-08 | Antecip Bioventures Ii Llc | Methods for the safe administration of imidazole or imidazolium compounds |
| US9820999B2 (en) | 2012-05-14 | 2017-11-21 | Antecip Bioventures Ii Llc | Neridronic acid for treating complex regional pain syndrome |
| US9844559B2 (en) | 2012-05-14 | 2017-12-19 | Antecip Bioventures Ii Llc | Neridronic acid for treating bone marrow lesions |
| US9925203B2 (en) | 2012-05-14 | 2018-03-27 | Antecip Bioventures Ii Llc | Compositions for administration of zoledronic acid or related compounds for treating low back pain |
| US9289441B2 (en) | 2014-08-08 | 2016-03-22 | Antecip Bioventures Ii Llc | Osteoclast inhibitors such as zoledronic acid for low back pain treatment |
| US10004756B2 (en) | 2014-05-15 | 2018-06-26 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome |
| US9827256B2 (en) | 2014-05-27 | 2017-11-28 | Antecip Bioventures Ii Llc | Compositions for administration of zoledronic acid or related compounds for treating lower back pain |
| US9999629B2 (en) | 2012-05-14 | 2018-06-19 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome |
| US9655908B2 (en) | 2012-05-14 | 2017-05-23 | Antecip Bioventures Ii Llc | Neridronic acid molecular complex for treating complex regional pain syndrome |
| US10413561B2 (en) | 2012-05-14 | 2019-09-17 | Antecip Bioventures Ii Llc | Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases |
| US9717747B2 (en) | 2012-05-14 | 2017-08-01 | Antecip Bioventures Ii Llc | Osteoclast inhibitors for knee conditions |
| US9662343B2 (en) | 2012-05-14 | 2017-05-30 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome |
| US9827192B2 (en) | 2012-05-14 | 2017-11-28 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome |
| US10350227B2 (en) | 2012-05-14 | 2019-07-16 | Antecip Bioventures Ii Llc | Neridronic acid for treating complex regional pain syndrome |
| US9956234B2 (en) | 2012-05-14 | 2018-05-01 | Antecip Bioventures Ii Llc | Osteoclast inhibitors for joint conditions |
| US9616078B2 (en) | 2012-05-14 | 2017-04-11 | Antecip Bioventures Ii Llc | Dosage forms for oral administration of zoledronic acid or related compounds for treating disease |
| US11654152B2 (en) | 2012-05-14 | 2023-05-23 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating disease |
| US10413560B2 (en) | 2012-05-14 | 2019-09-17 | Antecip Bioventures Ii Llc | Dosage forms for oral administration of zoledronic acid or related compounds for treating disease |
| US8865757B1 (en) | 2014-05-28 | 2014-10-21 | Antecip Bioventures Ii Llp | Therapeutic compositions comprising imidazole and imidazolium compounds |
| US9789128B2 (en) | 2012-05-14 | 2017-10-17 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome |
| US10493085B2 (en) | 2012-05-14 | 2019-12-03 | Antecip Bioventures Ii Llc | Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases |
| US10028908B2 (en) | 2012-05-14 | 2018-07-24 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome |
| US9669040B2 (en) | 2012-05-14 | 2017-06-06 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome |
| US9770457B2 (en) | 2012-05-14 | 2017-09-26 | Antecip Bioventures Ii Llc | Neridronic acid for treating bone marrow lesion |
| US10034890B2 (en) | 2012-05-14 | 2018-07-31 | Antecip Bioventures Ii Llc | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome |
| US9795622B2 (en) | 2012-05-14 | 2017-10-24 | Antecip Bioventures Ii Llc | Neridronic acid for treating pain associated with a joint |
| US20150051175A1 (en) * | 2012-05-14 | 2015-02-19 | Antecip Bioventures Ii Llc | Co-Administration of Steroids and Zoledronic Acid to Prevent and Treat Pain |
| CN102671205B (zh) * | 2012-05-29 | 2013-07-10 | 安吉东来药用辅料有限责任公司 | 紫菜多糖片剂赋形剂、药物片剂及药物片剂的制备方法 |
| CN102698281B (zh) * | 2012-05-29 | 2013-07-03 | 安吉东来药用辅料有限责任公司 | 海带多糖片剂赋形剂、药物片剂及药物片剂的制备方法 |
| CN102671200B (zh) * | 2012-05-29 | 2013-07-10 | 安吉东来药用辅料有限责任公司 | 低聚异麦芽糖片剂赋形剂、药物片剂及制备方法 |
| CN102697744B (zh) * | 2012-05-29 | 2013-11-27 | 安吉东来药用辅料有限责任公司 | 阿洛糖片剂赋形剂、药物片剂及药物片剂的制备方法 |
| CN102698280B (zh) * | 2012-05-29 | 2013-07-10 | 安吉东来药用辅料有限责任公司 | 塔格糖片剂赋形剂、药物片剂及药物片剂的制备方法 |
| CN102671204B (zh) * | 2012-05-29 | 2013-07-10 | 安吉东来药用辅料有限责任公司 | 古洛糖片剂赋形剂、药物片剂及药物片剂的制备方法 |
| CN102688206B (zh) * | 2012-05-29 | 2014-08-20 | 石药集团中奇制药技术（石家庄）有限公司 | 一种匹伐他汀钙片及其制备方法 |
| CN102671206B (zh) * | 2012-05-29 | 2013-07-10 | 安吉东来药用辅料有限责任公司 | 低聚果糖片剂赋形剂、药物片剂及药物片剂的制备方法 |
| CN102671203B (zh) * | 2012-05-29 | 2013-07-10 | 安吉东来药用辅料有限责任公司 | 裙带菜多糖片剂赋形剂、药物片剂及药物片剂的制备方法 |
| US9127069B1 (en) | 2014-06-11 | 2015-09-08 | Antecip Bioventures LLC | Compositions comprising rank/rankl antagonists and related compounds for treating pain |
| RS61884B1 (sr) | 2014-10-06 | 2021-06-30 | Signal Pharm Llc | Supstituisana aminopurinska jedinjenja, kompozicije koje ih sadrže i postupci za lečenje u kojima se koriste |
| CN104771761A (zh) * | 2015-03-19 | 2015-07-15 | 深圳国源国药有限公司 | 一种创新药用辅料硅化微晶纤维素及其制备方法 |
| BR112018070163A2 (pt) | 2016-04-01 | 2019-01-29 | Signal Pharm Llc | compostos de aminopurina substituída, composições e métodos de tratamento |
| SMT202100604T1 (it) | 2016-04-01 | 2021-11-12 | Signal Pharm Llc | (1s,4s)-4-(2-(((3s,4r)-3-fluorotetraidro-2h-piran-4-il)ammino)-8-((2,4,6-triclorofenil)ammino)-9h-purin-9-il)-1-metilcicloesano-1-carbossammide e metodi per il loro utilizzo |
| KR20200062270A (ko) | 2017-10-04 | 2020-06-03 | 셀진 코포레이션 | 시스-4-[2-｛[(3s,4r)-3-플루오로옥산-4-일]아미노｝-8-(2,4,6-트리클로로아닐리노)-9h-퓨린-9-일]-1-메틸시클로헥산-1-카르복스아미드의 조성물 및 이용 방법 |
| JP2020536100A (ja) | 2017-10-04 | 2020-12-10 | セルジーン コーポレイション | シス−４−［２−｛［（３ｓ，４ｒ）−３−フルオロキサン−４−イル］アミノ｝−８−（２，４，６−トリクロロアニリノ）−９ｈ−プリン−９−イル］−１−メチルシクロヘキサン−１−カルボキサミドの製造プロセス |
| CN110787140A (zh) * | 2018-08-01 | 2020-02-14 | 北京万全德众医药生物技术有限公司 | 比拉斯汀片剂及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0275468B1 (de) * | 1986-12-20 | 1991-02-06 | Roche Diagnostics GmbH | Clodronat-haltige Arzneimittel und Verfahren zur Herstellung derselben |
| RU2134103C1 (ru) * | 1993-05-15 | 1999-08-10 | Берингер Маннхайм ГмбХ | Таблетка с улучшенной биодоступностью биологически активного вещества и вещество, повышающее биодоступность |
| FI94926C (fi) * | 1993-11-12 | 1995-11-27 | Leiras Oy | Menetelmä klodronaattivalmisteen valmistamiseksi |
| US5585115A (en) * | 1995-01-09 | 1996-12-17 | Edward H. Mendell Co., Inc. | Pharmaceutical excipient having improved compressability |
-
1997
- 1997-09-19 FI FI973733A patent/FI109088B/fi not_active IP Right Cessation
-
1998
- 1998-09-18 KR KR1020007002955A patent/KR20010024184A/ko not_active Ceased
- 1998-09-18 BR BR9812480-3A patent/BR9812480A/pt not_active Application Discontinuation
- 1998-09-18 DE DE29824938U patent/DE29824938U1/de not_active Expired - Lifetime
- 1998-09-18 EP EP98945336A patent/EP1027037B1/en not_active Expired - Lifetime
- 1998-09-18 CA CA002301185A patent/CA2301185C/en not_active Expired - Lifetime
- 1998-09-18 HU HU0004383A patent/HU226118B1/hu unknown
- 1998-09-18 DE DE1027037T patent/DE1027037T1/de active Pending
- 1998-09-18 ID IDW20000735A patent/ID24423A/id unknown
- 1998-09-18 CN CN98809173A patent/CN1124130C/zh not_active Expired - Lifetime
- 1998-09-18 PL PL339290A patent/PL191166B1/pl unknown
- 1998-09-18 ES ES98945336T patent/ES2212341T3/es not_active Expired - Lifetime
- 1998-09-18 CZ CZ20000787A patent/CZ298675B6/cs not_active IP Right Cessation
- 1998-09-18 NZ NZ503766A patent/NZ503766A/en not_active IP Right Cessation
- 1998-09-18 HR HR20000142A patent/HRP20000142B1/xx not_active IP Right Cessation
- 1998-09-18 UA UA2000042105A patent/UA73078C2/uk unknown
- 1998-09-18 AU AU92685/98A patent/AU737738B2/en not_active Expired
- 1998-09-18 EA EA200000317A patent/EA002331B1/ru not_active IP Right Cessation
- 1998-09-18 SI SI9830599T patent/SI1027037T1/xx unknown
- 1998-09-18 WO PCT/FI1998/000735 patent/WO1999015155A1/en not_active Ceased
- 1998-09-18 PT PT98945336T patent/PT1027037E/pt unknown
- 1998-09-18 EE EEP200000096A patent/EE04218B1/xx unknown
- 1998-09-18 IL IL13513098A patent/IL135130A/en not_active IP Right Cessation
- 1998-09-18 SK SK393-2000A patent/SK284088B6/sk not_active IP Right Cessation
- 1998-09-18 DK DK98945336T patent/DK1027037T3/da active
- 1998-09-18 TR TR2000/00722T patent/TR200000722T2/xx unknown
- 1998-09-18 DE DE69820287T patent/DE69820287T2/de not_active Expired - Lifetime
- 1998-09-18 JP JP2000512526A patent/JP3589977B2/ja not_active Expired - Lifetime
- 1998-09-18 AT AT98945336T patent/ATE255410T1/de active
-
2000
- 2000-03-14 IS IS5404A patent/IS5404A/is unknown
- 2000-03-17 NO NO20001417A patent/NO327728B1/no not_active IP Right Cessation
- 2000-03-22 BG BG104265A patent/BG64886B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI973733L (fi) | Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi | |
| FI980043A7 (fi) | Ääntä vaimentava tuote ja menetelmä sen valmistamiseksi | |
| FI964028L (fi) | Uusi farmaseuttinen formulaatio ja menetelmä | |
| FI19992360L (fi) | Tuote ja menetelmä sen valmistamiseksi | |
| FI944961L (fi) | Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi | |
| FI973426L (fi) | Bentsopyraania sisältävät yhdisteet ja menetelmä niiden valmistamiseksi | |
| FI955362A0 (fi) | Symmetrointilaite ja menetelmä sen suunnittelemiseksi | |
| FI971880L (fi) | Helposti sulavan kantajan sisältävä farmaseuttinen koostumus ja menetelmä sen valmistamiseksi | |
| FI952260L (fi) | Propiofenonijohdos ja menetelmä sen valmistamiseksi | |
| FI974494L (fi) | Paikannusmenetelmä ja paikannusjärjestely | |
| FI970518A7 (fi) | Majoneesin tapainen tuote ja menetelmä sen valmistamiseksi | |
| FI951468A7 (fi) | Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö | |
| FI980246A0 (fi) | Menetelmä keittimen käyttämiseksi ja keitin | |
| EE04681B1 (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
| FI972264L (fi) | Betaiinituote, menetelmä sen valmistamiseksi, ja sen käyttö | |
| FI971622L (fi) | Hammasimplanttijärjestelmä ja menetelmä sen valmistamiseksi | |
| FI972988L (fi) | Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä | |
| FI972186L (fi) | Menetelmä isomaltuloosin ja muiden tuotteiden valmistamiseksi | |
| EE03387B1 (et) | Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks | |
| FI943103A7 (fi) | Puolikiinteä farmaseuttinen aine ja menetelmä sen valmistamiseksi | |
| FI973434A7 (fi) | Aminotetralonijohdannaisia ja menetelmä niiden valmistamiseksi | |
| FI973006L (fi) | Vesiliukoinen merkkiaine ja menetelmä sen valmistamiseksi | |
| FI982412L (fi) | Rehu ja menetelmä sen valmistamiseksi | |
| FI972464A7 (fi) | Diaminoeetterin diklavulanaattisuola ja menetelmä sen valmistamiseksi | |
| FI953260A7 (fi) | Farmaseuttiset koostumukset ja menetelmä niiden valmistamiseksi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| SPCL | Withdrawal, rejection or dismissal of a supplementary protection certificate |
Spc suppl protection certif: L20020014 |
|
| PC | Transfer of assignment of patent |
Owner name: BAYER SCHERING PHARMA OY Free format text: BAYER SCHERING PHARMA OY |
|
| MA | Patent expired |